Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Parainfluenza Virus 2, Human"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 39
Tytuł:
Inhibitory effects of kaempferol, quercetin and luteolin on the replication of human parainfluenza virus type 2 in vitro.
Autorzy:
Sakai-Sugino K; Department of Microbiology, Mie University Graduate School of Medicine, Mie, Japan.; Department of Life and Environmental Science, Tsu City College, Mie, Japan.; Microbiology and Immunology Section, Department of Clinical Nutrition, Graduate School of Health Science, Suzuka University of Medical Science, Mie, Japan.
Uematsu J; Microbiology and Immunology Section, Department of Clinical Nutrition, Graduate School of Health Science, Suzuka University of Medical Science, Mie, Japan.
Yamamoto H; Faculty of Pharmaceutical Sciences, Suzuka University of Medical Science, Mie, Japan.
Kihira S; Department of Life Vista, Nara Saho College, Nara, Japan.
Kawano M; Department of Microbiology, Mie University Graduate School of Medicine, Mie, Japan.
Nishio M; Department of Microbiology, Mie University Graduate School of Medicine, Mie, Japan.
Tsurudome M; Department of Microbiology, Mie University Graduate School of Medicine, Mie, Japan.
Sekijima H; Department of Forensic Medicine and Sciences, Mie University Graduate School of Medicine, Mie, Japan.
O'Brien M; Graduate School of Nursing, Mie Prefectural College of Nursing, Mie, Japan.
Komada H; Microbiology and Immunology Section, Department of Clinical Nutrition, Graduate School of Health Science, Suzuka University of Medical Science, Mie, Japan.
Pokaż więcej
Źródło:
Drug discoveries & therapeutics [Drug Discov Ther] 2024 Mar 20; Vol. 18 (1), pp. 16-23. Date of Electronic Publication: 2024 Feb 20.
Typ publikacji:
Journal Article
MeSH Terms:
Quercetin*/pharmacology
Kaempferols*/pharmacology
Humans ; Parainfluenza Virus 2, Human ; Luteolin/pharmacology ; Flavonoids ; RNA, Messenger/metabolism ; Virus Replication
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Evaluation of a Live-Attenuated Human Parainfluenza Virus Type 2 Vaccine in Adults and Children.
Autorzy:
Karron RA; Center for Immunization Research, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Herbert K; Center for Immunization Research, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Wanionek K; Center for Immunization Research, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Schmidt AC; RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Bethesda, Maryland, USA.; Present Affiliation: Bill & Melinda Gates Medical Research Institute, Cambridge, Massachusetts, USA.
Schaap-Nutt A; RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Bethesda, Maryland, USA.
Collins PL; RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Bethesda, Maryland, USA.
Buchholz UJ; RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Bethesda, Maryland, USA.
Pokaż więcej
Źródło:
Journal of the Pediatric Infectious Diseases Society [J Pediatric Infect Dis Soc] 2023 Apr 18; Vol. 12 (3), pp. 173-176.
Typ publikacji:
Clinical Trial, Phase I; Journal Article
MeSH Terms:
Parainfluenza Virus 2, Human*
Vaccines, Synthetic*
Adult ; Child ; Humans ; Antibodies, Viral ; Parainfluenza Virus 1, Human ; Parainfluenza Virus 3, Human ; Vaccines, Attenuated
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A fatal case of neonatal viral sepsis caused by human parainfluenza virus type 3.
Autorzy:
Chen X; Beijing Key Laboratory of Pediatric Respiratory Infection Diseases, Key Laboratory of Major Diseases in Children, Ministry of Education, National Clinical Research Center for Respiratory Diseases, Research Unit of Critical Infection in Children, Laboratory of Infection and Virology, Beijing Children's Hospital, Chinese Academy of Medical Sciences, Beijing Pediatric Research Institute, Capital Medical University, National Center for Children's Health, No. 56 Nan-li-shi Road, Xicheng District, Beijing, 2019RU016, 100045, China.
Wang H; Department of Neonatology, Neonatal Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, 100045, China.
Li Q; Beijing Key Laboratory of Pediatric Respiratory Infection Diseases, Key Laboratory of Major Diseases in Children, Ministry of Education, National Clinical Research Center for Respiratory Diseases, Research Unit of Critical Infection in Children, Laboratory of Infection and Virology, Beijing Children's Hospital, Chinese Academy of Medical Sciences, Beijing Pediatric Research Institute, Capital Medical University, National Center for Children's Health, No. 56 Nan-li-shi Road, Xicheng District, Beijing, 2019RU016, 100045, China.
Qi Y; Department of Neonatology, Neonatal Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, 100045, China.
Li F; Beijing Key Laboratory of Pediatric Respiratory Infection Diseases, Key Laboratory of Major Diseases in Children, Ministry of Education, National Clinical Research Center for Respiratory Diseases, Research Unit of Critical Infection in Children, Laboratory of Infection and Virology, Beijing Children's Hospital, Chinese Academy of Medical Sciences, Beijing Pediatric Research Institute, Capital Medical University, National Center for Children's Health, No. 56 Nan-li-shi Road, Xicheng District, Beijing, 2019RU016, 100045, China.
He W; Department of Neonatology, Neonatal Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, 100045, China.
Wang Q; Infection Business Unit, Tianjin Novogene Med LAB Co., Ltd, Tianjin, 301700, China.
Jin F; Department of Neonatology, Neonatal Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, 100045, China.
Guo Y; Infection Business Unit, Tianjin Novogene Med LAB Co., Ltd, Tianjin, 301700, China.
Hei M; Department of Neonatology, Neonatal Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, 100045, China. .
Xie Z; Beijing Key Laboratory of Pediatric Respiratory Infection Diseases, Key Laboratory of Major Diseases in Children, Ministry of Education, National Clinical Research Center for Respiratory Diseases, Research Unit of Critical Infection in Children, Laboratory of Infection and Virology, Beijing Children's Hospital, Chinese Academy of Medical Sciences, Beijing Pediatric Research Institute, Capital Medical University, National Center for Children's Health, No. 56 Nan-li-shi Road, Xicheng District, Beijing, 2019RU016, 100045, China. .
Pokaż więcej
Źródło:
Virology journal [Virol J] 2023 Oct 27; Vol. 20 (1), pp. 248. Date of Electronic Publication: 2023 Oct 27.
Typ publikacji:
Case Reports; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Shock, Septic*/diagnosis
Respiratory Tract Infections*
Child ; Male ; Humans ; Infant, Newborn ; Parainfluenza Virus 3, Human/genetics ; Viremia ; Mutation ; Parainfluenza Virus 2, Human
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Inhibitory effect of traditional herbal (kampo) medicines on the replication of human parainfluenza virus type 2 in vitro.
Autorzy:
Uematsu J; Microbiology and Immunology Section, Department of Clinical Nutrition, Graduate School of Health Science, Suzuka University of Medical Science, Suzuka, Mie, Japan.
Yamamoto H; Faculty of Pharmaceutical Sciences, Suzuka University of Medical Science, Suzuka, Mie, Japan.
Kihira S; Department of Clinical Nutrition, Faculty of Health Science, Suzuka University of Medical Science, Suzuka, Mie, Japan.
Sakai-Sugino K; Department of Clinical Nutrition, Faculty of Health Science, Suzuka University of Medical Science, Suzuka, Mie, Japan.
Ishiyama Y; Department of Clinical Nutrition, Faculty of Health Science, Suzuka University of Medical Science, Suzuka, Mie, Japan.
Chindoh M; Department of Clinical Nutrition, Faculty of Health Science, Suzuka University of Medical Science, Suzuka, Mie, Japan.
Baba A; Department of Clinical Nutrition, Faculty of Health Science, Suzuka University of Medical Science, Suzuka, Mie, Japan.
Kazuta R; Department of Clinical Nutrition, Faculty of Health Science, Suzuka University of Medical Science, Suzuka, Mie, Japan.
Hasegawa T; Department of Clinical Nutrition, Faculty of Health Science, Suzuka University of Medical Science, Suzuka, Mie, Japan.
Fujimoto K; Department of Clinical Nutrition, Faculty of Health Science, Suzuka University of Medical Science, Suzuka, Mie, Japan.
Funauchi A; Department of Clinical Nutrition, Faculty of Health Science, Suzuka University of Medical Science, Suzuka, Mie, Japan.
Itoh A; Department of Clinical Nutrition, Faculty of Health Science, Suzuka University of Medical Science, Suzuka, Mie, Japan.
Ookohchi A; Department of Clinical Nutrition, Faculty of Health Science, Suzuka University of Medical Science, Suzuka, Mie, Japan.
Satoh S; Department of Clinical Nutrition, Faculty of Health Science, Suzuka University of Medical Science, Suzuka, Mie, Japan.
Maeda Y; Department of Clinical Nutrition, Faculty of Health Science, Suzuka University of Medical Science, Suzuka, Mie, Japan.
Kawano M; Department of Microbiology, Mie University Graduate School of Medicine, Tsu, Mie, Japan.
Tsurudome M; Department of Microbiology, Mie University Graduate School of Medicine, Tsu, Mie, Japan.
Nishio M; Department of Microbiology, Mie University Graduate School of Medicine, Tsu, Mie, Japan.
Hirai K; Faculty of Pharmaceutical Sciences, Suzuka University of Medical Science, Suzuka, Mie, Japan.
O'Brien M; Graduate School of Mie Prefectural College of Nursing, Tsu, Mie, Japan.
Komada H; Microbiology and Immunology Section, Department of Clinical Nutrition, Graduate School of Health Science, Suzuka University of Medical Science, Suzuka, Mie, Japan.
Pokaż więcej
Źródło:
Drug discoveries & therapeutics [Drug Discov Ther] 2021 Sep 22; Vol. 15 (4), pp. 180-188. Date of Electronic Publication: 2021 Aug 26.
Typ publikacji:
Journal Article
MeSH Terms:
Medicine, Kampo*
Parainfluenza Virus 2, Human*/genetics
Cell Line ; Humans ; RNA, Messenger ; Virus Replication
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Recent increase in the detection of human parainfluenza virus during the coronavirus disease-2019 pandemic in the Republic of Korea.
Autorzy:
Kim HM; Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency, 187 Osongsaengmyeong2-ro, Osong-eup, Heungdeok-gu, Cheongju-si, Republic of Korea.
Rhee JE; Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency, 187 Osongsaengmyeong2-ro, Osong-eup, Heungdeok-gu, Cheongju-si, Republic of Korea.
Lee NJ; Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency, 187 Osongsaengmyeong2-ro, Osong-eup, Heungdeok-gu, Cheongju-si, Republic of Korea.
Woo SH; Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency, 187 Osongsaengmyeong2-ro, Osong-eup, Heungdeok-gu, Cheongju-si, Republic of Korea.
Park AK; Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency, 187 Osongsaengmyeong2-ro, Osong-eup, Heungdeok-gu, Cheongju-si, Republic of Korea.
Lee J; Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency, 187 Osongsaengmyeong2-ro, Osong-eup, Heungdeok-gu, Cheongju-si, Republic of Korea.
Yoo CK; Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency, Cheongju-si, Republic of Korea.
Kim EJ; Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency, 187 Osongsaengmyeong2-ro, Osong-eup, Heungdeok-gu, Cheongju-si, Republic of Korea. .
Pokaż więcej
Źródło:
Virology journal [Virol J] 2022 Dec 12; Vol. 19 (1), pp. 215. Date of Electronic Publication: 2022 Dec 12.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Influenza, Human*/epidemiology
COVID-19*/diagnosis
COVID-19*/epidemiology
Coronavirus*
Respiratory Tract Infections*
Infant ; Humans ; Pandemics ; Parainfluenza Virus 1, Human ; Parainfluenza Virus 2, Human
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Human parainfluenza 2 & 4: Clinical and genetic epidemiology in the UK, 2013-2017, reveals distinct disease features and co-circulating genomic subtypes.
Autorzy:
Chellapuri A; School of Life Sciences, University of Nottingham, Nottingham, UK.
Smitheman M; School of Life Sciences, University of Nottingham, Nottingham, UK.
Chappell JG; School of Life Sciences, University of Nottingham, Nottingham, UK.; Wolfson Centre for Global Virus Research, University of Nottingham, Nottingham, UK.
Clark G; Clinical Microbiology, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Howson-Wells HC; Clinical Microbiology, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Berry L; Clinical Microbiology, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Ball JK; School of Life Sciences, University of Nottingham, Nottingham, UK.; Wolfson Centre for Global Virus Research, University of Nottingham, Nottingham, UK.
Irving WL; School of Life Sciences, University of Nottingham, Nottingham, UK.; Wolfson Centre for Global Virus Research, University of Nottingham, Nottingham, UK.; Clinical Microbiology, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Tarr AW; School of Life Sciences, University of Nottingham, Nottingham, UK.; Wolfson Centre for Global Virus Research, University of Nottingham, Nottingham, UK.
McClure CP; School of Life Sciences, University of Nottingham, Nottingham, UK.; Wolfson Centre for Global Virus Research, University of Nottingham, Nottingham, UK.
Pokaż więcej
Źródło:
Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2022 Nov; Vol. 16 (6), pp. 1122-1132. Date of Electronic Publication: 2022 Jun 07.
Typ publikacji:
Journal Article
MeSH Terms:
Paramyxoviridae Infections*/diagnosis
Paramyxoviridae Infections*/epidemiology
Respiratory Tract Infections*/epidemiology
Adult ; C-Reactive Protein ; Child ; Genomics ; Humans ; Molecular Epidemiology ; Parainfluenza Virus 1, Human/genetics ; Parainfluenza Virus 2, Human/genetics ; Parainfluenza Virus 3, Human/genetics ; Retrospective Studies ; United Kingdom/epidemiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Seasonal epidemiological and clinical characteristics of pediatric patients with human parainfluenza virus infection by serotype: a retrospective study.
Autorzy:
Han JY; Department of Pediatrics, Daejeon St. Mary's Hospital, The Catholic University of Korea, Daejeon, Republic of Korea.; Department of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Suh W; Department of Pediatrics, Daejeon St. Mary's Hospital, The Catholic University of Korea, Daejeon, Republic of Korea.; Department of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Han SB; Department of Pediatrics, Hangang Sacred Heart Hospital, College of Medicine, Hallym University, 12 Beodeunaru-ro 7-gil, Yeongdeungpo-gu, Seoul, 07247, Republic of Korea. .
Pokaż więcej
Źródło:
Virology journal [Virol J] 2022 Sep 06; Vol. 19 (1), pp. 141. Date of Electronic Publication: 2022 Sep 06.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Paramyxoviridae Infections*
Respiratory Tract Infections*/epidemiology
Child ; Humans ; Parainfluenza Virus 1, Human ; Parainfluenza Virus 2, Human ; Parainfluenza Virus 3, Human ; Parainfluenza Virus 4, Human ; Retrospective Studies ; Seasons ; Serogroup
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Inhibitions of human parainfluenza virus type 2 replication by ribavirin and mycophenolate mofetil are restored by guanosine and S-(4-nitrobenzyl)-6-thioinosine.
Autorzy:
Uematsu J; Microbiology and Immunology Section, Department of Clinical Nutrition, Graduate School of Health Science, Suzuka University of Medical Science, Suzuka, Mie, Japan.
Sakai-Sugino K; Department of Clinical Nutrition, Faculty of Health Science, Suzuka University of Medical Science, Suzuka, Mie, Japan.
Kihira-Nakanishi S; Department of Clinical Nutrition, Faculty of Health Science, Suzuka University of Medical Science, Suzuka, Mie, Japan.
Yamamoto H; Faculty of Pharmaceutical Sciences, Suzuka University of Medical Science, Suzuka, Mie, Japan.
Hirai K; Faculty of Pharmaceutical Sciences, Suzuka University of Medical Science, Suzuka, Mie, Japan.
Kawano M; Department of Microbiology, Mie University Graduate School of Medicine, Tsu, Mie, Japan.
Nishio M; Department of Microbiology, Mie University Graduate School of Medicine, Tsu, Mie, Japan.
Tsurudome M; Department of Microbiology, Mie University Graduate School of Medicine, Tsu, Mie, Japan.
O'Brien M; Graduate School of Mie Prefectural College of Nursing, Tsu, Mie, Japan.
Komada H; Microbiology and Immunology Section, Department of Clinical Nutrition, Graduate School of Health Science, Suzuka University of Medical Science, Suzuka, Mie, Japan.
Pokaż więcej
Źródło:
Drug discoveries & therapeutics [Drug Discov Ther] 2019; Vol. 13 (6), pp. 314-321.
Typ publikacji:
Journal Article
MeSH Terms:
Antiviral Agents/*pharmacology
Guanosine/*pharmacology
Parainfluenza Virus 2, Human/*physiology
Thioinosine/*analogs & derivatives
Animals ; Cell Line ; Macaca mulatta ; Mycophenolic Acid/pharmacology ; Parainfluenza Virus 2, Human/drug effects ; RNA, Viral/genetics ; Ribavirin/pharmacology ; Thioinosine/pharmacology ; Virus Internalization/drug effects ; Virus Replication/drug effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Glycyrrhizin inhibits human parainfluenza virus type 2 replication by the inhibition of genome RNA, mRNA and protein syntheses.
Autorzy:
Sakai-Sugino K; Department of Clinical Nutrition, Faculty of Health Science, Suzuka University of Medical Science.
Uematsu J; Microbiology and Immunology Section, Department of Clinical Nutrition, Graduate School of Suzuka University of Medical Science.
Kamada M; Department of Clinical Nutrition, Faculty of Health Science, Suzuka University of Medical Science.
Taniguchi H; Department of Clinical Nutrition, Faculty of Health Science, Suzuka University of Medical Science.
Suzuki S; Department of Clinical Nutrition, Faculty of Health Science, Suzuka University of Medical Science.
Yoshimi Y; Department of Clinical Nutrition, Faculty of Health Science, Suzuka University of Medical Science.
Kihira S; Department of Clinical Nutrition, Faculty of Health Science, Suzuka University of Medical Science.
Yamamoto H; Faculty of Pharmaceutical Sciences, Suzuka University of Medical Science.
Kawano M; Department of Microbiology, Mie University Graduate School of Medicine.
Tsurudome M; Department of Microbiology, Mie University Graduate School of Medicine.
O'Brien M; Graduate School of Mie Prefectural College of Nursing.
Itoh M; Cokey Systems Co., Ltd.
Komada H; Microbiology and Immunology Section, Department of Clinical Nutrition, Graduate School of Suzuka University of Medical Science.
Pokaż więcej
Źródło:
Drug discoveries & therapeutics [Drug Discov Ther] 2017 Nov 22; Vol. 11 (5), pp. 246-252. Date of Electronic Publication: 2017 Oct 24.
Typ publikacji:
Journal Article
MeSH Terms:
Glycyrrhizic Acid/*pharmacology
Parainfluenza Virus 2, Human/*drug effects
RNA, Messenger/*drug effects
RNA, Viral/*drug effects
Virus Replication/*drug effects
Actin Cytoskeleton/drug effects ; Animals ; Cell Line ; Cell Survival/drug effects ; Genome, Viral/drug effects ; Giant Cells/drug effects ; HN Protein/biosynthesis ; HN Protein/drug effects ; Macaca mulatta ; Parainfluenza Virus 2, Human/genetics ; Parainfluenza Virus 2, Human/metabolism ; Protein Synthesis Inhibitors/pharmacology ; RNA, Messenger/metabolism ; RNA, Viral/metabolism ; Real-Time Polymerase Chain Reaction ; Viral Fusion Proteins/biosynthesis ; Viral Fusion Proteins/drug effects ; Viral Proteins/biosynthesis ; Viral Proteins/drug effects ; Virus Replication/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Synthesis of human parainfluenza virus 2 nucleocapsid protein in yeast as nucleocapsid-like particles and investigation of its antigenic structure.
Autorzy:
Bulavaitė A; Institute of Biotechnology, Vilnius University, V.A. Graičiūno 8, 02241, Vilnius, Lithuania. .
Lasickienė R; Institute of Biotechnology, Vilnius University, V.A. Graičiūno 8, 02241, Vilnius, Lithuania.
Vaitiekaitė A; Institute of Biotechnology, Vilnius University, V.A. Graičiūno 8, 02241, Vilnius, Lithuania.
Sasnauskas K; Institute of Biotechnology, Vilnius University, V.A. Graičiūno 8, 02241, Vilnius, Lithuania.
Žvirblienė A; Institute of Biotechnology, Vilnius University, V.A. Graičiūno 8, 02241, Vilnius, Lithuania.
Pokaż więcej
Źródło:
Applied microbiology and biotechnology [Appl Microbiol Biotechnol] 2016 May; Vol. 100 (10), pp. 4523-34. Date of Electronic Publication: 2016 Jan 29.
Typ publikacji:
Journal Article
MeSH Terms:
Parainfluenza Virus 2, Human*
Antigens, Viral/*genetics
Nucleocapsid Proteins/*biosynthesis
Amino Acid Sequence ; Animals ; Antibodies, Monoclonal/immunology ; Antigens, Viral/immunology ; Cloning, Molecular ; Epitope Mapping ; Escherichia coli/genetics ; Escherichia coli/metabolism ; Genetic Vectors ; Mice ; Mice, Inbred BALB C ; Nucleocapsid Proteins/genetics ; Protein Conformation ; Recombinant Proteins/genetics ; Recombinant Proteins/metabolism ; Saccharomyces cerevisiae/genetics ; Saccharomyces cerevisiae/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Isolation & molecular characterization of human parainfluenza virus in Chennai, India.
Autorzy:
Indumathi CP
Gunanasekaran P
Kaveri K; Department of Virology, King Institute of Preventive Medicine & Research, Chennai, India.
Arunagiri K
Mohana S
Sheriff AK
SureshBabu BV
Padmapriya P
Senthilraja R
Fathima G
Pokaż więcej
Źródło:
The Indian journal of medical research [Indian J Med Res] 2015 Nov; Vol. 142 (5), pp. 583-90.
Typ publikacji:
Journal Article
MeSH Terms:
Parainfluenza Virus 1, Human/*isolation & purification
Parainfluenza Virus 2, Human/*isolation & purification
Paramyxoviridae Infections/*virology
Humans ; India ; Parainfluenza Virus 1, Human/genetics ; Parainfluenza Virus 2, Human/genetics ; Paramyxoviridae Infections/physiopathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Successful Treatment of Parainfluenza Virus Respiratory Tract Infection With DAS181 in 4 Immunocompromised Children.
Autorzy:
Waghmare A; Seattle Children's Hospital , Washington ; University of Washington , Seattle ; Fred Hutchinson Cancer Research Center , Seattle, Washington.
Wagner T; Seattle Children's Hospital , Washington ; University of Washington , Seattle.
Andrews R; Seattle Children's Hospital , Washington ; University of Washington , Seattle ; Fred Hutchinson Cancer Research Center , Seattle, Washington.
Smith S; Seattle Children's Hospital , Washington ; University of Washington , Seattle.
Kuypers J; University of Washington , Seattle.
Boeckh M; University of Washington , Seattle ; Fred Hutchinson Cancer Research Center , Seattle, Washington.
Moss R; Ansun BioPharma, San Diego, California.
Englund JA; Seattle Children's Hospital , Washington ; University of Washington , Seattle.
Pokaż więcej
Źródło:
Journal of the Pediatric Infectious Diseases Society [J Pediatric Infect Dis Soc] 2015 Jun; Vol. 4 (2), pp. 114-8. Date of Electronic Publication: 2014 May 14.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Immunocompromised Host/*physiology
Parainfluenza Virus 2, Human/*drug effects
Parainfluenza Virus 3, Human/*drug effects
Recombinant Fusion Proteins/*pharmacology
Recombinant Fusion Proteins/*therapeutic use
Respiratory Tract Infections/*drug therapy
Respirovirus Infections/*drug therapy
Rubulavirus Infections/*drug therapy
Alanine Transaminase/blood ; Alanine Transaminase/drug effects ; Aspartate Aminotransferases/blood ; Aspartate Aminotransferases/drug effects ; Child ; Child, Preschool ; Humans ; Infant ; Leukemia, Myeloid, Acute/complications ; Male ; Neuroblastoma/complications ; Parainfluenza Virus 2, Human/physiology ; Parainfluenza Virus 3, Human/physiology ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/complications ; Prospective Studies ; Random Allocation ; Recombinant Fusion Proteins/administration & dosage ; Respiratory Tract Infections/diagnosis ; Severe Combined Immunodeficiency/complications ; Transplantation/adverse effects ; Viral Load/drug effects ; Viral Load/physiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Neurogenic pulmonary edema following febrile status epilepticus in a 22-month-old infant with multiple respiratory virus co-detection: a case report.
Autorzy:
Takagi Y; Department of Pediatrics, Showa General Hospital, 8-1-1 Hanakoganei, Kodaira, Tokyo, 187-8510, Japan.; Department of Emergency Medicine and Critical Care, Showa General Hospital, 8-1-1 Hanakoganei, Kodaira, Tokyo, 187-8510, Japan.
Imamura T; Department of Emergency Medicine and Critical Care, Showa General Hospital, 8-1-1 Hanakoganei, Kodaira, Tokyo, 187-8510, Japan.; Department of Virology, Tohoku University Graduate School of Medicine, 2-1 Seiryo, Aoba, Sendai, 980-8575, Japan.
Endo S; Department of Pediatrics, Showa General Hospital, 8-1-1 Hanakoganei, Kodaira, Tokyo, 187-8510, Japan.
Hayashi K; Department of Pediatrics, Showa General Hospital, 8-1-1 Hanakoganei, Kodaira, Tokyo, 187-8510, Japan.
Akiyama S; Department of Pediatrics, Showa General Hospital, 8-1-1 Hanakoganei, Kodaira, Tokyo, 187-8510, Japan.
Ikuta Y; Department of Pediatrics, Showa General Hospital, 8-1-1 Hanakoganei, Kodaira, Tokyo, 187-8510, Japan.
Kawaguchi T; Department of Pediatrics, Showa General Hospital, 8-1-1 Hanakoganei, Kodaira, Tokyo, 187-8510, Japan.
Sumita T; Department of Pediatrics, Showa General Hospital, 8-1-1 Hanakoganei, Kodaira, Tokyo, 187-8510, Japan.
Katori T; Department of Pediatrics, Showa General Hospital, 8-1-1 Hanakoganei, Kodaira, Tokyo, 187-8510, Japan.
Hashino M; Pathogen Genomics Center, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku, Tokyo, 162-8640, Japan.
Saito S; Influenza Virus Research Center, National Institute of Infectious Diseases, 4-7-1 Gakuen, Musashimurayama, Tokyo, 208-0011, Japan.
Odagiri T; Influenza Virus Research Center, National Institute of Infectious Diseases, 4-7-1 Gakuen, Musashimurayama, Tokyo, 208-0011, Japan.
Oba K; Department of Pediatrics, Showa General Hospital, 8-1-1 Hanakoganei, Kodaira, Tokyo, 187-8510, Japan.
Kuroda M; Pathogen Genomics Center, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku, Tokyo, 162-8640, Japan.
Kageyama T; Influenza Virus Research Center, National Institute of Infectious Diseases, 4-7-1 Gakuen, Musashimurayama, Tokyo, 208-0011, Japan. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2020 Jun 01; Vol. 20 (1), pp. 388. Date of Electronic Publication: 2020 Jun 01.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Pulmonary Edema/*etiology
Respiratory Tract Infections/*virology
Central Nervous System Diseases/etiology ; Central Nervous System Diseases/therapy ; Coronavirus/isolation & purification ; Coronavirus Infections ; Female ; Fever/complications ; Humans ; Infant ; Influenza, Human ; Gammainfluenzavirus/isolation & purification ; Molecular Diagnostic Techniques ; Nasopharynx/virology ; Parainfluenza Virus 2, Human/isolation & purification ; Pulmonary Edema/diagnostic imaging ; Pulmonary Edema/therapy ; Respiratory Tract Infections/complications ; Status Epilepticus
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A versatile platform technology for recombinant vaccines using non-propagative human parainfluenza virus type 2 vector.
Autorzy:
Ohtsuka J; Department of Microbiology and Molecular Genetics, Mie University Graduate School of Medicine, Tsu, Japan.; Research Center for Development of Recombinant VLP Vaccines, Research Institutes of Excellence, Mie University, Tsu, Japan.; BioComo Inc., Komono, Mie, Japan.
Fukumura M; Department of Microbiology and Molecular Genetics, Mie University Graduate School of Medicine, Tsu, Japan. .; Research Center for Development of Recombinant VLP Vaccines, Research Institutes of Excellence, Mie University, Tsu, Japan. .; BioComo Inc., Komono, Mie, Japan. .
Furuyama W; Division of Global Epidemiology, Research Center for Zoonosis Control, Hokkaido University, Sapporo, Japan.; Laboratory of Virology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rocky Mountain Laboratories, Hamilton, MT, USA.
Wang S; Department of Neural Regeneration and Cell Communication, Mie University Graduate School of Medicine, Tsu, Japan.
Hara K; Department of Microbiology and Molecular Genetics, Mie University Graduate School of Medicine, Tsu, Japan.; Project Division of ALA Advanced Medical Research, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Maeda M; Multi-Modal Microstructure Analysis Unit, RIKEN-JEOL Collaboration Center, Kobe, Japan.
Tsurudome M; Department of Microbiology and Molecular Genetics, Mie University Graduate School of Medicine, Tsu, Japan.; Research Center for Development of Recombinant VLP Vaccines, Research Institutes of Excellence, Mie University, Tsu, Japan.; Department of Biomedical Sciences, College of Life and Health Sciences, Chubu University, Kasugai, Japan.
Miyamoto H; Division of Global Epidemiology, Research Center for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Kaito A; Department of Neural Regeneration and Cell Communication, Mie University Graduate School of Medicine, Tsu, Japan.; Department of Physiology, Mie University Graduate School of Medicine, Tsu, Japan.
Tsuda N; Department of Microbiology and Molecular Genetics, Mie University Graduate School of Medicine, Tsu, Japan.
Kataoka Y; Multi-Modal Microstructure Analysis Unit, RIKEN-JEOL Collaboration Center, Kobe, Japan.
Mizoguchi A; Research Center for Development of Recombinant VLP Vaccines, Research Institutes of Excellence, Mie University, Tsu, Japan.; Department of Neural Regeneration and Cell Communication, Mie University Graduate School of Medicine, Tsu, Japan.
Takada A; Division of Global Epidemiology, Research Center for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Nosaka T; Department of Microbiology and Molecular Genetics, Mie University Graduate School of Medicine, Tsu, Japan. .; Research Center for Development of Recombinant VLP Vaccines, Research Institutes of Excellence, Mie University, Tsu, Japan. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2019 Sep 09; Vol. 9 (1), pp. 12901. Date of Electronic Publication: 2019 Sep 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Genetic Vectors/*genetics
Parainfluenza Virus 2, Human/*genetics
Vaccines, Synthetic/*genetics
Vaccinology/*methods
Animals ; Antibodies, Neutralizing/immunology ; Antibodies, Viral/immunology ; Chlorocebus aethiops ; Epitopes/genetics ; Epitopes/immunology ; Gene Order ; Genetic Engineering ; Humans ; Mice ; Neutralization Tests ; T-Lymphocyte Subsets/immunology ; T-Lymphocyte Subsets/metabolism ; Vero Cells
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Intranasally administered antigen 85B gene vaccine in non-replicating human Parainfluenza type 2 virus vector ameliorates mouse atopic dermatitis.
Autorzy:
Kitagawa H; Department of Dermatology, Mie University, Graduate School of Medicine, Tsu, Mie, Japan.
Kawano M
Yamanaka K
Kakeda M
Tsuda K
Inada H
Yoneda M
Sakaguchi T
Nigi A
Nishimura K
Komada H
Tsurudome M
Yasutomi Y
Nosaka T
Mizutani H
Pokaż więcej
Źródło:
PloS one [PLoS One] 2013 Jul 03; Vol. 8 (7), pp. e66614. Date of Electronic Publication: 2013 Jul 03 (Print Publication: 2013).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antigens, Bacterial/*genetics
Antigens, Bacterial/*immunology
Dermatitis, Atopic/*immunology
Genetic Vectors/*genetics
Parainfluenza Virus 2, Human/*genetics
Vaccines, DNA/*administration & dosage
Vaccines, DNA/*immunology
Animals ; Cell Line ; Cytokines/genetics ; Dermatitis, Atopic/chemically induced ; Dermatitis, Atopic/pathology ; Disease Models, Animal ; Gene Expression ; Genetic Vectors/immunology ; Humans ; Immunoglobulin E/blood ; Immunoglobulin E/immunology ; Male ; Mice ; Oxazolone/adverse effects ; Oxazolone/immunology ; Parainfluenza Virus 2, Human/immunology ; RNA, Messenger/genetics ; Skin/immunology ; Skin/metabolism ; Skin/pathology ; T-Lymphocytes, Regulatory/immunology ; T-Lymphocytes, Regulatory/metabolism ; Vaccines, DNA/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Epidemiology and clinical presentation of the four human parainfluenza virus types.
Autorzy:
Liu WK; State Key Laboratory of Respiratory Diseases (Guangzhou Medical University), 1 Kang Da Road, Guangzhou, Guangdong 510230, China.
Liu Q
Chen DH
Liang HX
Chen XK
Huang WB
Qin S
Yang ZF
Zhou R
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2013 Jan 23; Vol. 13, pp. 28. Date of Electronic Publication: 2013 Jan 23.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Parainfluenza Virus 1, Human*/genetics
Parainfluenza Virus 1, Human*/isolation & purification
Parainfluenza Virus 2, Human*/genetics
Parainfluenza Virus 2, Human*/isolation & purification
Parainfluenza Virus 3, Human*/genetics
Parainfluenza Virus 3, Human*/isolation & purification
Paramyxoviridae Infections/*diagnosis
Paramyxoviridae Infections/*epidemiology
Adolescent ; Adult ; Age Factors ; Aged ; Aged, 80 and over ; Child ; Child, Preschool ; China/epidemiology ; Female ; Humans ; Infant ; Infant, Newborn ; Male ; Middle Aged ; Parainfluenza Virus 4, Human/genetics ; Parainfluenza Virus 4, Human/isolation & purification ; Seasons ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Human parainfluenza virus type 2 hemagglutinin-neuramindase gene: sequence and phylogenetic analysis of the Saudi strain Riyadh 105/2009.
Autorzy:
Almajhdi FN; Department of Botany and Microbiology, College of Science, King Saud University, P,O, Box, 2455, Riyadh, 11451, Kingdom of Saudi Arabia. />Alshaman MS
Amer HM
Pokaż więcej
Źródło:
Virology journal [Virol J] 2012 Dec 22; Vol. 9, pp. 316. Date of Electronic Publication: 2012 Dec 22.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Genes, Viral*
Phylogeny*
HN Protein/*genetics
Parainfluenza Virus 2, Human/*genetics
Amino Acid Sequence ; Amino Acid Substitution ; Child, Preschool ; Databases, Nucleic Acid ; Female ; Humans ; Parainfluenza Virus 2, Human/classification ; Parainfluenza Virus 2, Human/enzymology ; Reverse Transcriptase Polymerase Chain Reaction ; Saudi Arabia ; Sequence Alignment ; Sequence Homology, Amino Acid ; Software ; Species Specificity
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Legume lectins inhibit human parainfluenza virus type 2 infection by interfering with the entry.
Autorzy:
Uematsu J; Microbiology and Immunology Section, Department of Clinical Nutrition, Graduate School of Suzuka University of Medical Science, 1001-1, Kishioka, Suzuka, Mie 510-0293, Japan. />Koyama A
Takano S
Ura Y
Tanemura M
Kihira S
Yamamoto H
Kawano M
Tsurudome M
O'Brien M
Komada H
Pokaż więcej
Źródło:
Viruses [Viruses] 2012 Jul; Vol. 4 (7), pp. 1104-15. Date of Electronic Publication: 2012 Jun 29.
Typ publikacji:
Journal Article
MeSH Terms:
Antiviral Agents/*pharmacology
Down-Regulation/*drug effects
Fabaceae/*chemistry
Lectins/*pharmacology
Parainfluenza Virus 2, Human/*drug effects
Parainfluenza Virus 2, Human/*physiology
Virus Internalization/*drug effects
Cell Line ; Humans ; Parainfluenza Virus 2, Human/genetics ; Rubulavirus Infections/virology ; Virus Replication/drug effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Infants hospitalized for Bordetella pertussis infection commonly have respiratory viral coinfections.
Autorzy:
Frassanito A; Department of Pediatrics, 'Sapienza' University of Rome, V.le Regina Elena 324, 00161, Rome, Italy.
Nenna R; Department of Pediatrics, 'Sapienza' University of Rome, V.le Regina Elena 324, 00161, Rome, Italy.
Nicolai A; Department of Pediatrics, 'Sapienza' University of Rome, V.le Regina Elena 324, 00161, Rome, Italy.
Pierangeli A; Molecular Medicine Department, 'Sapienza' University of Rome, Rome, Italy.
Tozzi AE; Multifactorial Disease and Complex Phenotype Research Area, Bambino Gesù Children's Hospital, Rome, Italy.
Stefanelli P; Department of Infectious, Parasitic & Immunomediated Disease, Istituto Superiore di Sanità, Rome, Italy.
Carsetti R; Immunology Unit, Immunology and Pharmacal Therapy Area, Bambino Gesù Children's Hospital, Rome, Italy.
Concato C; Virology Unit, Bambino Gesù Children's Hospital, Rome, Italy.
Schiavoni I; Department of Infectious, Parasitic & Immunomediated Disease, Istituto Superiore di Sanità, Rome, Italy.
Midulla F; Department of Pediatrics, 'Sapienza' University of Rome, V.le Regina Elena 324, 00161, Rome, Italy. .
Pokaż więcej
Corporate Authors:
Pertussis study group
Źródło:
BMC infectious diseases [BMC Infect Dis] 2017 Jul 12; Vol. 17 (1), pp. 492. Date of Electronic Publication: 2017 Jul 12.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Respiratory Tract Infections/*diagnosis
Whooping Cough/*diagnosis
Bordetella pertussis/genetics ; Bordetella pertussis/isolation & purification ; Child, Preschool ; Coronavirus/genetics ; Coronavirus/isolation & purification ; Female ; Hospitalization ; Humans ; Infant ; Male ; Nasal Cavity/microbiology ; Nasal Cavity/virology ; Parainfluenza Virus 1, Human/isolation & purification ; Parainfluenza Virus 2, Human/genetics ; Parainfluenza Virus 2, Human/isolation & purification ; RNA, Viral/genetics ; RNA, Viral/metabolism ; Real-Time Polymerase Chain Reaction ; Respiratory Syncytial Virus, Human/genetics ; Respiratory Syncytial Virus, Human/isolation & purification ; Respiratory Tract Infections/complications ; Respiratory Tract Infections/virology ; Retrospective Studies ; Rhinovirus/genetics ; Rhinovirus/isolation & purification ; Severity of Illness Index ; Whooping Cough/complications ; Whooping Cough/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 39

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies